Abstract: The present invention relates to a stable sustained release injectable formulation based on poly(D,L-lactide-co-glycolide) microparticles comprising Levothyroxine. It also relates to a process for the preparation of microparticles and use to control hypothyroidism in adults, congenital hypothyroidism in infants and acquired hypothyroidism in children.
| # | Name | Date |
|---|---|---|
| 1 | 202437034563-STATEMENT OF UNDERTAKING (FORM 3) [01-05-2024(online)].pdf | 2024-05-01 |
| 2 | 202437034563-REQUEST FOR EXAMINATION (FORM-18) [01-05-2024(online)].pdf | 2024-05-01 |
| 3 | 202437034563-PRIORITY DOCUMENTS [01-05-2024(online)].pdf | 2024-05-01 |
| 4 | 202437034563-FORM 18 [01-05-2024(online)].pdf | 2024-05-01 |
| 5 | 202437034563-FORM 1 [01-05-2024(online)].pdf | 2024-05-01 |
| 6 | 202437034563-DECLARATION OF INVENTORSHIP (FORM 5) [01-05-2024(online)].pdf | 2024-05-01 |
| 7 | 202437034563-COMPLETE SPECIFICATION [01-05-2024(online)].pdf | 2024-05-01 |
| 8 | 202437034563-FORM 3 [05-07-2024(online)].pdf | 2024-07-05 |
| 9 | 202437034563-Proof of Right [06-07-2024(online)].pdf | 2024-07-06 |
| 10 | 202437034563-FORM-26 [06-07-2024(online)].pdf | 2024-07-06 |